CN106093435B - The application of Echinococcus granulosus Glutaredoxin 1 - Google Patents

The application of Echinococcus granulosus Glutaredoxin 1 Download PDF

Info

Publication number
CN106093435B
CN106093435B CN201610554270.6A CN201610554270A CN106093435B CN 106093435 B CN106093435 B CN 106093435B CN 201610554270 A CN201610554270 A CN 201610554270A CN 106093435 B CN106093435 B CN 106093435B
Authority
CN
China
Prior art keywords
kit
grx1
echinococcus granulosus
glutaredoxin
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610554270.6A
Other languages
Chinese (zh)
Other versions
CN106093435A (en
Inventor
杨光友
宋星桔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Agricultural University
Original Assignee
Sichuan Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Agricultural University filed Critical Sichuan Agricultural University
Priority to CN201610554270.6A priority Critical patent/CN106093435B/en
Publication of CN106093435A publication Critical patent/CN106093435A/en
Application granted granted Critical
Publication of CN106093435B publication Critical patent/CN106093435B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Abstract

The present invention relates to biological technical field, specifically disclose application of the Echinococcus granulosus Glutaredoxin 1 in the immunizing antigen and/or kit for preparing detection echinococcosis granulosa, it can be identified as immunizing antigen by the sheep positive serum of natural infection echinococcosis granulosa, when being detected applied to indirect ELISA, possesses higher specificity and sensitivity, clinical detection coincidence rate is up to 97.9%.There is good diagnosis effect as the detection method that immunizing antigen is established using Echinococcus granulosus Glutaredoxin 1, can be used for the preliminary screening of epidemic-stricken area sheep echinococcosis granulosa.

Description

The application of Echinococcus granulosus glutaredoxin -1
Technical field
The present invention relates to biological technical field, more particularly to Echinococcus granulosus glutaredoxin -1 should With.
Background technology
Echinococcus granulosus (Echinococcus granulosus) category band section (Taeniidae) Echinococcus (Echinococcus), wherein silk ribbon phase parasitized larvae is in caused Echinococcus Granulosus Cysts in animal and the liver of people, lung and other organs Disease, also known as capsule echinococcosis, it is a kind of Amphixenosis, main parasitic is in a variety of mammal bodies such as people and domestic animal.90% More than Echinococcus Granulosus Cysts packing be grown on the liver of host, lungs or be grown on liver lung simultaneously.Echinococcosis granulosa is in generation Criticality is distributed, and causes a series of economy and public health problem.In some Prevalent district, its infection rate may be up to 5-10%, The death rate is up to 2-4%.It is estimated that global people's capsule hydatidosis at least loses the disability adjusted life years of 1-3.6 million every year (DALYs), and economic loss caused by animal capsule hydatidosis is annual is at least 2,000,000,000 dollars.Therefore, the World Health Organization Hydatidosis is classified as《Ignored tropical disease》, as its 2008-2015 keypoint control plan.
At present, the research of echinococcosis granulosa immunodiagnosis is concentrated mainly on thick cyst fluid antigen, but its complicated component, Be difficult to a large amount of purifications, the defect such as antigenic source is unstable, cost is high, specificity is low.Shortage standard is effectively special Property recombinant antigen is a still unsolved problem in echinococcosis granulosa immunodiagnosis.
The content of the invention
In view of this, it is an object of the invention to provide Echinococcus granulosus glutaredoxin -1 (Eg-Grx1) application, It can identify there is good immunogenicity, and have by the sheep positive serum of natural infection echinococcosis granulosa Higher specificity and sensitivity, reduce the cross reaction with other Taeniidae disease positive serums.
Glutaredoxin (glutaredoxin, Grx), also known as thioltransferase (thioltmnsferase), be sulfydryl- The important component of disulfide bond redox enzyme family.Glutaredoxin family and thioredoxin family together maintain organism The balance of internal oxidition reduction, it is two important systems of the sulfhydryl oxidase reduction-state regulation for participating in protein.Grx using GSH as Direct electron donor, NADPH (are mainly provided) oxygen of albumen containing sulfydryl as original electron donor, regulation cell by cysteine Change reducing condition, played a significant role during cell signalling.
At present, the research on glutaredoxin is concentrated mainly in trypanosome and plasmodium, plasmodium Grx1 (Pf-Grx1) It is located in cytoplasm, there is HEDS activity and reduce the characteristics such as ribonucleotide reductase.The researchs such as Tripathi are found The characteristics of Pf-Grx1 energy high temperature resistant, resistance to denaturant and resistance to PH change.The clonal expressions such as Marquez go out the Grx eggs of trypanosoma bocagei In vain, it is found that it plays a significant role in the redox metabolism of parasite.But on glutaredoxin on parasite Report it is more rare.Therefore, the present invention has carried out bioinformatics to Echinococcus granulosus glutaredoxin -1 (Eg-Grx1) Analysis, and rEg-Grx1 albumen is given expression to by reverse transcription, anti-rEg-Grx1 polyclonal antibody is prepared, the albumen is carried out Immunoblotting assay shows that it can identify there is good immunogene by the sheep positive serum of natural infection echinococcosis granulosa Property, echinococcosis granulosa indirect ELISA diagnostic method is established using rEg-Grx1 albumen, is provided for the prevention and control of echinococcosis granulosa Monitoring means.
Therefore, the present invention proposes Echinococcus granulosus glutaredoxin -1 and is preparing the immune of detection echinococcosis granulosa Application in antigen and/or kit.
Wherein, preferably, the kit is ELISA detection kit or immune-blotting method kit.
Meanwhile present invention also offers a kind of ELISA detection kit for detecting echinococcosis granulosa, including particulate spine ball Tapeworm glutaredoxin -1 (being coated with as antigen) and ELISA detection kit conventional constituents.The kit is according between Connect ELISA Cleaning Principles.
Preferably, the ELISA detection kit conventional constituents include antigen coat liquid, ELISA Plate, confining liquid, HRP The secondary antibody and tmb substrate of mark.
It is further preferred that the confining liquid is 5% skimmed milk power;The secondary antibody of the HRP marks is the goat of HRP marks Or sheep anti-rabbit secondary antibody.
In specific ELISA detection process, antigen coat optimum condition is 4 DEG C and stayed overnight that antigen optium concentration is 1.6 μ For g/ per hole, optimal serum-dilution concentration is 1:320, optimal confining liquid and sealing condition are that 37 DEG C of 5% skimmed milk power closes 1h, blood The clear Best Times that are incubated are 37 DEG C of 1.5h, and it is 37 DEG C of 1h that secondary antibody, which is incubated Best Times, and the optimal diluted concentration of secondary antibody is 1:When 3000, The optimum condition of substrate colour developing is 37 DEG C of 15min, and in the above conditions, the P/N values for measuring yin and yang attribute serum are 3.04
Preferably, the ELISA detection kit conventional constituents also include chromogenic reaction terminate liquid H2SO4, cleaning solution PBST and dilution PBS.
The present invention first extracts Echinococcus granulosus total serum IgE, then carries out reverse transcription and obtains cDNA, according to GeneDB (http://www.genedb.org/Homepage/Egranulosus) in the Eg-Grx1 (EgrG_000124800) that announces Gene order, with the software Design primers of Primer Premier 5.0 expand purpose fragment, then carry out sequence verification, its with Eg-Grx1 (EgrG_000124800) sequence homology reaches 100% in GeneDB.It is finally coupled in expression vector, turns Enter expression in escherichia coli, obtain the reverse transcription recombinant protein rEg-Grx1 of Echinococcus granulosus glutaredoxin -1.
Western blotting shows that rEg-Grx1 can be identified by the sheep positive serum of natural infection echinococcosis granulosa, has good Good immunogenicity.Result of indirect ELISA shows that the cut-off values of this method are 0.481, and specificity and sensitivity are respectively 64.3% (9/14) and 1:3200, and with sheep brain Echinococcus hydatid cyst serum no cross reaction.
From above technical scheme, the invention provides Echinococcus granulosus glutaredoxin -1 to prepare detection particulate Application in the immunizing antigen and/or kit of hydatidosis, it can be by natural infection Echinococcus Granulosus Cysts as immunizing antigen The sheep positive serum identification of disease, when being detected applied to indirect ELISA, possesses higher specificity and sensitivity, clinical detection Coincidence rate is up to 97.9%.It is that the detection method that immunizing antigen is established has well with Echinococcus granulosus glutaredoxin -1 Diagnosis effect, it can be used for the preliminary screening of epidemic-stricken area sheep echinococcosis granulosa.
Brief description of the drawings
Fig. 1 show Eg-Grx1PCR amplification gel figures;Wherein, M is DNA molecular quality standard DL2000;1 is Eg- Grx1cDNA PCR primers;2 be blank control;
Fig. 2 show rEg-Grx1 western blot gel figures;Wherein, M is Protein standards;1 is recombinant bacterium Middle rEg-Grx1 expression;2 be rEg-Grx1 after purification;3 be that rabbit-anti rEg-Grx1-IgG identifies rEg-Grx1;4 be health Rabbit anteserum identifies rEg-Grx1;5 identify rEg-Grx1 for the sheep positive serum of natural infection echinococcosis granulosa;6 be health Sheep serum identifies rEg-Grx1;7 be that rabbit-anti rEg-Grx1-IgG identifies protoscolex thick leach protein;8 be that healthy rabbit anteserum identifies Protoscolex thick leach protein;
Fig. 3 show specific analysis chart of the indirect ELISA to rEg-Grx1;Wherein, abscissa is followed successively by from left to right The anti-cenurus cerebralis positive serum of sheep, the anti-cysticercus tenuicollis positive serum of goat, the anti-Echinococcus Granulosus Cysts positive serum of sheep; Cuto-off value represent critical value;
Fig. 4 show the clinical test results figure of indirect ELISA;Wherein, abscissa is followed successively by positive serum from left to right And negative serum;Cuto-off value represent critical value.
Embodiment
The invention discloses the application of Echinococcus granulosus glutaredoxin -1, those skilled in the art can use for reference herein Content, it is suitably modified technological parameter realization.In particular, all similar replacements and change are to people in the art It is it will be apparent that they are considered as being included in the present invention for member.Application of the present invention has passed through preferred embodiment It is described, related personnel can substantially not depart from present invention, application as described herein carried out in spirit and scope Change is suitably changed with combining, to realize and using the technology of the present invention.
In the specific embodiment of the invention, the involved material of each experiment and reagent are as follows:
1st, main agents
Total RNA from animal tissues extraction agent box (TRIzol.R.Total RNA Isolation.Reagent) and reverse transcription Kit (RevertAid First Strand cDNA Synthesis Kit), purchased from GIBCOBRL companies;DNA Marker, Protein Marker, restriction enzyme (BamH I, Hind III, EcoRI, Xho I), T4DNA ligases, Purchased from TaKaRa companies;Ago-Gel QIAquick Gel Extraction Kit, Ni-NTA Agarose, purchased from Qiagen companies;TaqPCR MasterMix, small amount plasmid extraction agent box, HRP-DAB substrate colour reagent boxes, purchased from the limited public affairs of Beijing Tiangeng biochemical technology Department;The goat anti-rabbit igg antibody of HRP marks, the rabbit-anti anti-goat IgG antibody of HRP marks, the rabbit-anti sheep IgG antibody of HRP marks, The goat anti-rabbit igg antibody of FITC marks is purchased from Wuhan doctor's moral biology Co., Ltd;IPTG, Freund's complete adjuvant and Freund are endless Full adjuvant, purchased from Sigma companies;HiTrap Protein A HP, purchased from Bio-Rad companies, PCR primer synthesis and be sequenced by The handsome bioengineering Co., Ltd in Shanghai completes;Other reagents are that domestic analysis is pure.
2nd, bacterial strain and plasmid vector
Host Strains bacillus coli DH 5 alpha, e. coli bl21 (DE3), pMD19-T Vector are purchased from TaKaRa companies; PET32a (+) carrier is provided by Sichuan Agricultural University's animal parasitosis laboratory.
3rd, the preparation of cushioning liquid and culture medium is commonly used
PBS Buffer①:Following reagent is weighed respectively in beaker:NaCl 8g, KCl 0.2g, Na2HPO41.42g KH2PO40.27g.Add about 500mL sterilizing distilled waters and mix dissolving, adding dense HCl makes pH reach 7.4, constant volume to 1L.High pressure Room temperature preservation after sterilizing.
Electrophoretic buffer (50 × TAE Buffer):Weigh 242g Tris and 37.2g Na2EDTA·2H2O in beaker, Add 500mL sterilizing distilled waters and mix dissolving, add 58mL CH3COOH is sufficiently stirred again, constant volume to 1L and room temperature preservation.
EB:0.1gEB is added in 100mL sterilizing distilled water, normal temperature preserves after packing.
LB culture mediums:Liquid culture medium:Triptone 10g, 5g Yeast Extract, 10g NaCl is weighed respectively to add Enter to be dissolved in 500mL sterilizings H in beaker2PH to 7.0 is adjusted in O and with caustic soda, autoclaving after constant volume to 1L, 4 DEG C of preservations.LB is put down Plate:Add 15g agar powders, autoclaving, 4 DEG C of preservations in per 1L solution.
IPTG solution:The isopropylthiogalactoside that electronic balance weighs 2g is dissolved in 8mL ultra-pure waters, is sufficiently stirred molten After solution plus water is to 10mL, and -20 DEG C are stored in the packing of EP pipes with after 0.45 μm of membrane filtration.
30% polyacrylamide solution:0.8g Bis-acrylamide and 29.2g Acrylamide are weighed, is added 50mL deionized waters mix dissolving, add water to 100mL, with 0.22 μm of membrane filtration.
1M Tris-HCl(pH 6.8):12.11g Tris is weighed in beaker, adds 80mL distilled waters to be sufficiently stirred molten Solution, enriching hydrochloric acid simultaneously uses acidometer to add water to 100mL after adjusting pH to 6.8, with 0.22 μm of membrane filtration.
1.5M Tris-HCl(pH 8.8):19g Tris is taken to add 50mL distilled waters to be sufficiently stirred dissolving in beaker, add Concentrated hydrochloric acid simultaneously uses acidometer to add water to 100mL, 4 DEG C of preservations after adjusting pH to 8.8.
10% lauryl sodium sulfate (SDS) solution:10g SDS is weighed in beaker, 80mL distilled waters is added and fully stirs 100mL is settled to after mixing dissolving, is preserved with normal temperature after 0.45 μm of membrane filtration.
10% ammonium persulfate solution:0.1g APS is weighed, adds water constant volume to be preserved to 1mL, normal temperature.
Coomassie brilliant blue staining liquid:0.1g Coomassie brilliant blues powder is weighed in 20mL alcohol with electronic balance, takes 100mL Concentrated phosphoric acid is preserved to 200mL with normal temperature after 0.45 μm of membrane filtration.
Ampicillin sodium solution (AMP):1gAmpicilin powder is weighed using electronic balance, it is abundant to draw 9mL ultra-pure waters 10mL is settled to after stirring and dissolving, degerming with 0.22 μm of filtering with microporous membrane, packing EP manages -20 DEG C of preservations.
4th, experimental animal
2 healthy new zealand rabbits, 1.4~2.2kg, purchased from Sichuan Agricultural University's experimental animal center.
With reference to embodiment, the present invention is expanded on further.
Embodiment 1:The extraction of Echinococcus Granulosus Cysts total serum IgE
Middle silk ribbon phase larva (Echinococcus Granulosus Cysts) packing of Echinococcus granulosus comes from the sheep liver of natural infection, sample Pick up from Xining, Qinghai or Szechwan Ganzi, Liquid nitrogen storage.
The Echinococcus Granulosus Cysts of Liquid nitrogen storage are taken out, are ground with mortar, are extracted referring next to the animal tissue RNA of Tiangeng Kit specification extracts total serum IgE.
(1) add 300 μ L lysates per 10-20mg protoscolexs, ground using grinding rod;
(2) Proteinase K (10 μ L) and RNase-Free ddH2O (590 μ L) are added into homogenate, it is anti-after mixing Answer 15min (56 DEG C).
(3) 5min (12,000rpm) is centrifuged, supernatant is transferred in clean pipe;0.5 times of supernatant is added in pipe The absolute ethyl alcohol of volume, it is transferred to after mixing in adsorption column, waste liquid is abandoned after centrifugation 1min (12,000rpm).
(4) in adsorption column plus after deproteinized matter liquid RW1 (350 μ L), centrifugation 1min (12,000rpm), waste liquid is abandoned.
(5) DNase I working solutions (80 μ L) are added into adsorption column, room temperature placing response 15min;Then add deproteinized matter liquid Waste liquid is abandoned after RW1 (350 μ L), centrifugation 1min (12,000rpm).
(6) 500 μ L rinsing liquids RW are added in adsorption column, are placed 2min (room temperature), are abandoned after centrifugation 1min (12,000rpm) useless Liquid.
(7) (6) are repeated.
(8) it is empty from abandoning waste liquid, dry remaining rinsing liquid.
(9) adsorption column is put into a new centrifuge tube, eluted with RNase-Free ddH2O (30-100 μ L), stood Echinococcus Granulosus Cysts Total RNAs extraction liquid is obtained after 2min (room temperature), centrifugation 2min (12,000rpm).
Embodiment 2:First chain cDNA synthesis
It is public with reference to Thermo with Oligo dT (18) for reverse transcription primer using the Echinococcus Granulosus Cysts total serum IgE of extracting as template Department's reverse transcription reagent box specification is operated:
(1) reactant mixture is prepared on ice
Oligo dT18 1μL
The μ L of template ribonucleic acid 1
DEPC ddH2O 1μL
(2) cooled on ice is gone to after 70 DEG C (5min) incubation
(3) following reactant is added in sequence on ice:
5reaction buffer 4μL
The μ L of ribonuclease inhibitor 1
The μ L of 10dNTP mixtures 2
(4) 37 DEG C (5min) adds RevertAid after being incubatedTMThe μ L of reverse transcriptase 1.
(5) PCR programs:42 DEG C, 1h;70 DEG C, 10min.
(6) cDNA obtained is in -80 DEG C of preservations.
Embodiment 3:The amplification of Eg-Grx1 genes
According to GeneDB (http://www.genedb.org/Homepage/Egranulosus) in announce Eg-Grx1 (EgrG_000124800) gene order, with the software Design primers of Primer Premier 5.0:
Upstream:5’-CCGGAATTCATGTGGCGCTTTTTATC-3 ' underscores are EcoR I
Downstream:5’-CCGCTCGAGCTCTAAAAGTTCAGCAAGTG-3 ' underscore Xho I
Amplification system (25 μ L):Each 1 μ L of DNA profiling, each μ L of 1 μ L, PCR Mixture 12.5 of upstream and downstream primer, sterilizing are double Steam the μ L of water 9.5.
Amplification condition:Pre-degeneration:95℃5min;38 circulation (denaturation:95 DEG C, 40s;Annealing:54 DEG C, 45s;Extension:72 DEG C, 45s);Finally extend:72 DEG C, 10min.
Go out a 351bp or so band (Fig. 1) using the cDNA of Echinociccus granulosus protoscolex as template amplification.
Embodiment 4:The recovery of PCR primer
Gel containing purpose band is cut, is put into EP pipes, weighs.Mesh is reclaimed using gel DNA QIAquick Gel Extraction Kits Fragment.After 400 μ LPC Buffer being added per 100mg gels, 55 DEG C of water-bath colloidal sols.After gel is completely dissolved, absorption is moved into In post, 60sec (12000rpm) is centrifuged, after then addition Washing Buffer washings centrifuge 2 times, sky centrifugation 2min (12000rpm).Ethanol smell in adsorption column is dried, 30 μ L Elution Buffer are added into adsorption column, centrifuges 2min (12000rpm), obtains target DNA fragment.
Embodiment 5:Eg-Grx1 gene clonings are sequenced and compared
(1) following reagent is mixed:The 4 μ L μ L of Solution 1,3.5 template DNA, 0.5 μ L pMD19-T Vector, it is put into and is put in 16 DEG C of thermostatted water connections centrifuge wink from after overnight.
(2) competent cell is gone out from -70 DEG C, room temperature takes 30 μ L to be put into sky EP pipes after melting, and will connect 8 overnight μ L and produces Thing adds EP and manages and gently blow and beat mixing with micro sample-adding rifle, is put into mixture of ice and water ice bath 30min at once.42 DEG C of water-bath 90s Ice bath 5min immediately.600 μ L LB solution is added in each EP pipes, 180r/min cultivates 1.5h in 37 DEG C.By the solution of mixing It is poured on LB flat boards, 37 DEG C of cooling 1h make dry tack free, on the contrary flat board is stayed overnight.
(3) picking colony adds 1mL LB solution and 1 μ LAMP solution, 160r/min concussion and cultivates 6h is extremely into empty EP pipes It is muddy.Draw the amplification of 1 μ L bacterium solutions and observed after product is run into electrophoresis.Choose the positive bacterium solution of electrophoresis observation and deliver to Invitrogen Company is sequenced.
The purpose fragment sequence that sequencing obtains is put into GeneDB databases and compared, through be sequenced obtained sequence with Eg-Grx1 (EgrG_000124800) sequence homology reaches 100% in GeneDB.
Embodiment 6:Eg-Grx1 gene clonings, identification and conversion
1st, plasmid extraction
Sequencing result compare it is correct after, bacterial strain is expanded and cultivated, small reagent is carried with reference to the plasmid of Tiangeng biochemistry Co., Ltd Box operating instruction is carried out:
(1) 3-5mL bacterium solutions are taken, precipitation is collected by centrifugation;
(2) suspension P1 suspension thallines are added, and adds lysate P2 and bacterium solution is cracked;
(3) add P3 and produce precipitation, upset mixing, 15min (12,000rpm) is centrifuged after standing 10min;
(4) supernatant is taken into collecting pipe, adds 600 μ L rinsing solution PW, is stood 2min, centrifugation 1min (12,000rpm), is abandoned Waste liquid;
(5) (4) are repeated;
(6) dry and reclaim plasmid with 90 μ L eluents after rinsing liquid.
2nd, plasmid enzyme restriction reclaims
By the pMD19-T-Eg-Grx1 of the extraction fast enzyme cutting double digestions of Takara EcoR I and Xho I, 37 DEG C of digestions 12min, system cumulative volume are 10 μ L:8 μ L, 10X QuickCut Green Buffer of T cloned plasmids 1 μ L, QuickBamH I With the μ L of Xho I 0.5.Wink is from taking-up point sample carries out 1% rapidly after 37 DEG C of water bath with thermostatic control 15min after being mixed with micro sample-adding rifle Agarose gel electrophoresis and glue reclaim.
3rd, purpose fragment connection expression vector
By 22 DEG C of connection 1.5h of the Eg-Grx1 purpose fragments of double digestion and pET28a (+) carrier, subsequent connection product conversion E.coli DH5 α competent cells, and be applied on the LB culture medium flat plates of amicillin resistance, 37 DEG C of culture 12h.Picking list Individual bacterium colony, enter performing PCR identification.
4th, pET28a-Eg-Grx1 recombinant plasmids double digestion is identified
Double digestion identification is carried out to recombinant plasmid, method is with reference to " 2, plasmid enzyme restriction recovery ".
Embodiment 7:Recombinate expression of the Eg-Grx1 in Escherichia coli
1st, the expression of recombinant protein
(1) correct recombinant plasmid pET28a (+)-Grx1 will be sequenced and be transferred to BL21 (DE3) expression bacterium.
(2) expression bacterium is inoculated in two bottles of fresh LB (the μ g/mL containing AMP 100) nutrient solutions containing 100mL, 37 DEG C are shaken Bed culture 3h (160r/min), derivant IPTG (1mmol/L), 37 DEG C of induction 5h (160r/ are added after being 0.6 to bacterium solution OD590 Min), another bottle is not added with IPTG and does control culture.
(3) take respectively to bacterium solution 1.5mL later in two new EP pipes, 4 DEG C of centrifugation 1min (12,000r/min) are received Collect thalline, be separately added into 10 μ L 5 × SDS loadings Buffer and 40 μ L PBS solutions, fully mix.
(4) boiling water boiling 10min, so that thalline fully ruptures, 4 DEG C of centrifugation 10min (12,000r/min), supernatant is taken to carry out SDS-PAGE。
(5) coomassie brilliant blue staining 1h is used, expression is observed after decolouring.
2nd, the soluble analysis of recombinant protein
Expression bacterium containing recombinant plasmid Pet28a-Eg-Grx1 is inoculated in the fluid nutrient medium of 500mL benzyls containing ammonia, 37 DEG C of cultures (170rpm) add optimal IPTG concentration, induce 6h to OD600=0.6 or so.Bacterium solution is centrifuged 10min (8000rpm), supernatant is abandoned, precipitation is suspended with lysate (20mM Tris-Cl, pH8.0), ultrasonication thalline.After broken Cellular lysate liquid centrifuges 10min (12,000rpm), precipitation and separation and supernatant under the conditions of 4 DEG C;Precipitation adds appropriate 8M urea Dissolving.Supernatant precipitation respectively takes 40 μ L, adds 10 μ L 5 × sds gel sample-loading buffers respectively, boils 10min, centrifuges 10min (12,000rpm), SDS-PAGE electrophoresis is carried out, whether analysis rEg-Grx1 is solubility expression.
3rd, SDS-PAGE electrophoresis detections
By protein electrophorese instrument (Bio-Rad) specification, electrophoresis tank is assembled.Prepare 12% separation gel and 5% concentration Glue;Gel is vertically arranged in electrophoretic buffer, sample and protein Marker are added in sample well;Regulation constant pressure is 80V, 20min;Then adjustment voltage is 200V.Gel is taken out after electrophoresis, with coomassie brilliant blue staining 1h, boiling water bath decolourizes 15min, observation of finally being taken a picture in gel imaging system.
4th, the purifying of recombinant protein
According to above-mentioned steps to recombinant bacterium induced expression, a large amount of recombinant protein bacterium solutions are obtained.
(1) 1,000mL bacterium solutions are taken, centrifugation 10min (8,000rpm), abandon supernatant, collect thalline.
(2) lysate is added in thalline.
(3) ultrasonic disruption, until bacterium solution is clarified.
(4) 10min (12,000rpm) is centrifuged, stays supernatant.
(5) nickel ion affinity chromatograph post is taken, 5-10 bed volume is balanced with Banding Buffer;
(6) by sample after 0.22 μm of membrane filtration loading;
(7) 5-10 bed volume is washed with Banding Buffer;
(8) eluted with the imidazole elution containing different gradients, and collect each eluting peak;
(9) after being cleaned with 400mM imidazole elutions, it is 0 to be washed with 20% ethanol to ion concentration, by pillar in 4 DEG C Preserve.
(10) albumen is subjected to ultrafiltration and concentration with super filter tube, repeatedly adds the displacement that PBS carries out solution, it is original to remove Imidazoles;
(11) after protein concentration, SDS-PAGE inspections are carried out, and with BCA quantification of protein kit measurement protein compressions Degree.
5th, result
Eg-Grx1 fragments are successfully connected on pET-28a carriers, and conversion enters induced expression in BL21 Escherichia coli. Under the conditions of 37 DEG C, expression quantity is maximum when inducing 6h with 1mM IPTG.The recombinant protein size of expression is 19kDa or so, is met pre- Phase size.Soluble analysis result shows that rEg-Grx1 is expressed as soluble protein.Recombinant protein after purification is single band (Fig. 2).
Embodiment 8:Analysis of Immunogenicity
1st, rabbit-anti rEg-Grx1-IgG preparation
By rEg-Grx1 albumen after purification respectively with Freund's complete adjuvant and incomplete Freund's adjuvant according to 1:1 ratio is mixed Conjunction prepares emulsion seedling.Subcutaneous four injecting immunes are carried out to two new zealand rabbits, are immunized once per two week of minor tick, for the first time Be subcutaneously injected with Freund's complete adjuvant and 200 μ g recombinant proteins it is immune, after recombinated three times with incomplete Freund's adjuvant and 200 μ g Albumen is subcutaneously injected immune.
After immune end, HiTrap ProteinA 1mL prepacked columns and HPLC purification systems (Bio-Rad) is used to purify blood Clearly, flow velocity is adjusted to 1.0mL/min, pillar 10min is washed using A2Buffer.The serum that 0.45 μm of NC membrane filtration is crossed is put into In pillar, 0.5mL/min.Eluted with 10-20ml B Buffer, collect the IgG eluted, and adjusted with 50mM Tris The PH of the IgG solution eluted.After balance with 20% ethanol wash pillar, until ion concentration is reduced to 0.Pass through SDS- PAGE identifies antibody purification situation.
2nd, Western blotting
(1) protein electrophorese gel is prepared according to the method described above, and SDS-PAGE electrophoresis is carried out to albumen after purification.
(2) after protein electrophorese terminates, the corresponding gel position where protein is taken, is put into transferring film buffer solution and is put down Weighing apparatus, totally 3 times, each 4min.
(3) nitrocellulose filter (NC films) and 24 layers of filter paper are placed in transfering buffering liquid and soak 5min.
(4) cathode electrode plate, 24 layers of filter paper, gel, NC films, 24 layers of filter paper are placed in into Bio-Rad half dry types in order to turn Print in groove, cover anode electrode plate.
(5) electrotransfer device is connected on electroporation, and adds transfering buffering liquid 35mA transfers 30min.
(6) after transfer terminates, NC films is taken out, are immersed in 3%BSA TBST, 4 DEG C of closings are overnight.
(7) after closing terminates, NC films are cut off, the negative and positive is separated, adds the primary antibody of 1: 1000 dilution, and room temperature is incubated After educating 2h, primary antibody is outwelled, film is quickly washed with TBST 3 times, 5min/ times.
(8) the Goat-anti-sheep IgG of HRP marks are pressed 1:After 1000 dilutions, NC films are added, are incubated at room temperature 2h Afterwards, secondary antibody is outwelled, film is quickly washed with TBST 3 times, 5min/ times.
(9) NC films are placed in plate, rinsed with fresh substrate nitrite ion until developing the color.
(10) after developing the color, NC film color development stoppings are rinsed with distilled water, and result is photographed to record.
3rd, result
Western blotting shows that rEg-Grx1 can be identified by echinococcosis granulosa positive sheep serum, and is single band (figure 2), illustrate that rEg-Grx1 has preferable immunogenicity.Protoscolex crude protein extract solution is identified with rabbit-anti rEg-Grx1-IgG, shown Show only single band, size is consistent with natural Eg-Grx1 (13.2kDa), and the recombinant protein for illustrating expression is rEg- really Grx1。
Embodiment 9:The foundation of indirect ELISA method
1st, indirect ELISA operating procedure
(1) pressed with antigen coat liquid and dilute rEg-Grx1 albumen than row, added in 96 ELISA Plates and wrapped per the μ L of hole 100 Quilt;
(2) coating buffer is outwelled, liquid in hole is patted dry, is washed with PBST, is repeated four times;
(3) after adding confining liquid (5% skimmed milk power) closing, wash four times;
(4) with the incubation of enzyme mark hole after PBS in proportion dilute serum, is added, liquid is outwelled, is washed four times;
(5) goat or the sheep anti-rabbit secondary antibody of the HRP marks diluted are added, is incubated, washs four times;
(6) soluble one pack system substrate TMB is added into hole under the conditions of lucifuge and carries out chromogenic reaction;
(7) 100 μ L 2M H are added in hole2SO4Terminating reaction, its OD value is determined when ultraviolet absorptivity is 450nm.
(8) liquid is outwelled, after patting dry, is washed four times by (2) Suo Shi, each 3min;
(9) liquid is outwelled, after patting dry, color reaction is carried out under the conditions of lucifuge, soluble one pack system bottom is added into hole Thing TMB, per the μ L of hole 100, it is incubated at room temperature 10~20min;
(10) 100 μ L 2M H are added into hole again2SO4Terminating reaction, 96 orifice plates are placed on ELIASA immediately, ultraviolet Absorbance determines its OD value when being 450nm.
2nd, optimum condition is determined
(1) optimal antigen and serum-dilution concentration is determined with Checkerboard titration method, rEg-Grx1 protein concentration is set to:0.2μ G/ is per hole, and 0.4 μ g/ are per hole, and 0.8 μ g/ are per hole, and 1.6 μ g/ are per hole, and 3.2 μ g/ are per hole, and 6.4 μ g/ are per hole, serum-dilution ratio:1: 20,1:40,1:80,1:160,1:320,1:640, with positive serum OD450 close to condition maximum 1, P/N as optimal.
(2) optium concentration of secondary antibody effect and time, 1 is set respectively:1000,1:2000,1:3000,1:4000,1:5000 Five diluted concentrations are groped.Secondary antibody action time be arranged to 37 DEG C 0.5 hour, 1 hour, 1.5 hours, 2 hours four groups, With positive serum OD450The condition maximum close to 1, P/N is as optimal.
(3) the antigen coat time determines, dilutes recombinant antigen with coating buffer, is coated with optimal diluted concentration, is coated with Time is respectively 37 DEG C of 1h, 37 DEG C 2h and 4 DEG C overnight 3 groups, with positive serum OD450The condition maximum close to 1, P/N is as most It is good.
(4) determination of confining liquid and off-period, respectively with 1%BSA, 3%BSA, 5%BSA, 1% skim milk, 3% skim milk, the closing of 5% skim milk.37 DEG C are closed off with optimal confining liquid 1 hour, 2 hours, 3 hours and 4 DEG C 4 overnight, with positive serum OD450The condition maximum close to 1, P/N is as optimal.
(5) determination of positive and negative seroreaction time, incubated according to the condition of determination to screen the optimal of positive and negative serum Educate the time, be set to 37 DEG C 0.5 hour, 1 hour, 1.5 hours, 2 hours 4 groups, with positive serum OD450Maximum close to 1, P/N Concentration is as optimal.
(6) determination of substrate developing time, 37 DEG C of conditions divide into 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes and 30 minutes developing times, determine OD450Value, with positive serum OD450Close to 1, P/N maximum times as optimal.
Result of indirect ELISA shows that the optimum condition that P/N values reach highest antigen coat is 4 DEG C and stayed overnight that antigen is optimal Concentration is the every holes of 1.6 μ g/, and the optimal diluted concentration of serum is 1:320, optimal confining liquid and sealing condition are 5% skimmed milk powers 37 DEG C closing 1h, sera incubation Best Times are 37 DEG C of 1.5h, and it is 37 DEG C of 1h that secondary antibody, which is incubated Best Times, the optimal diluted concentration of secondary antibody For 1:When 3000, the optimum condition of substrate colour developing is 37 DEG C of 15min, and in the above conditions, the P/N values for measuring yin and yang attribute serum are 3.04。
3rd, the determination of critical value
At optimum conditions, the OD of 24 parts of sheep echinococcosis granulosa negative serums is determined450.Three repetitions are set.According to Critical value=+ 3 times of average value standard deviation calculates.
With the OD of 24 parts of sheep negative serum samples450Value determines critical value, by statistical analysis, calculates 24 parts of silk flosses Sheep negative serum sample OD450The average value of value is 0.296, standard deviation 0.0615.According to calculation formula:Critical value=feminine gender Sample OD450+ 3 times of standard deviations of average value, it is 0.481 to draw critical value, i.e. OD450>When 0.481, it can determine that in theory as the positive, OD450<0.481 can determine that as feminine gender.
4th, replica test in criticizing
The coated plank of same batch is taken, 5 parts of detection is known as the positive sheep serum of echinococcosis granulosa, every part of setting 3 repeating holes, according to the ELISA method having built up, carry out batch interior repetition and test, calculate the coefficient of variation, detect this method Repeatability in batch.
Replica test result shows that between 0.583%-2.014%, average value is the coefficient of variation in plate in batch 1.191%.
5th, replica test between criticizing
3 coated planks of batch are taken, at optimum conditions, detect the positive sheep serum of 3 parts of echinococcosis granulosas, often Part sets 3 repeating holes, according to the ELISA method having built up, carries out repeating to test between criticizing, the calculating coefficient of variation, detection is somebody's turn to do Method batch between repeatability.
Replica test result shows that between 0.914%-1.558%, average value is the coefficient of variation between plate between batch 1.153%.
6th, specific test
The anti-cysticercus tenuicollis positive serum of goat, the anti-cenurus cerebralis serum of sheep are entered respectively with the indirect ELISA of foundation Row detection, detect its specificity.
The anti-cenurus cerebralis serum of sheep and the anti-cysticercus tenuicollis positive serum of goat are entered respectively with the indirect ELISA of foundation Row detection, only there is cross reaction in as a result display, with a sheep brain Echinococcus hydatid cyst serum with four goat Cysticercosis Tenuicollis serum Cross reaction (Fig. 3) be present, therefore, its specificity is 64.3% (9/14).
7th, sensitivity test
3 parts of positive serums are made into doubling dilution, from 1:100 to 1:201800, according to criterion, determine its sensitivity.
3 parts of positive serums are made into doubling dilution, be as a result shown in dilution 3200 times when, OD450Average value is 0.567, is still belonged to In the positive, and when diluting 6400 times, OD450Average value is 0.392, less than critical value, accordingly, it is determined that its sensitivity is 1: 3200。
8th, clinical test
With the indirect ELISA method of foundation respectively to 24 parts of echinococcosis granulosa feminine gender sheep serums and 24 points of particulate spine balls The positive sheep serum of larva of a tapeworm or the cercaria of a schistosome disease is detected, and the reliability of this method is judged according to critical value.
The indirect ELISA method of foundation is carried out with 24 parts of sheep echinococcosis granulosa positive serums and 24 parts of negative serums Clinical detection (is shown in Table 1 and Fig. 4), as a result shows the OD of 23 parts of sheep echinococcosis granulosa positive serums450It is all higher than critical value, 24 parts of negative serum OD450Respectively less than critical value, the coincidence rate of detection are up to 97.9%.
The clinical serum sample OD of table 1450
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, under the premise without departing from the principles of the invention, some improvements and modifications can also be made, these improvements and modifications also should It is considered as protection scope of the present invention.

Claims (6)

1. Echinococcus granulosus glutaredoxin -1 is in the immunizing antigen and/or kit for preparing detection echinococcosis granulosa Using.
2. apply according to claim 1, it is characterised in that the kit is ELISA detection kit or Western blotting Detection kit.
3. a kind of ELISA detection kit for detecting echinococcosis granulosa, it is characterised in that including Echinococcus granulosus paddy oxygen also Albumen -1 and ELISA detection kit conventional constituents, the ELISA detection kit conventional constituents include antigen coat liquid, enzyme Target, confining liquid, the secondary antibody and tmb substrate of HRP marks.
4. kit according to claim 3, it is characterised in that the confining liquid is 5% skimmed milk power.
5. kit according to claim 3, it is characterised in that goat or silk floss of the secondary antibody of the HRP marks for HRP marks Goat-anti rabbit secondary antibody.
6. according to kit described in claim 3-5 any one, it is characterised in that the ELISA detection kit routine group Dividing also includes chromogenic reaction terminate liquid H2SO4, cleaning solution PBST and dilution PBS.
CN201610554270.6A 2016-07-14 2016-07-14 The application of Echinococcus granulosus Glutaredoxin 1 Active CN106093435B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610554270.6A CN106093435B (en) 2016-07-14 2016-07-14 The application of Echinococcus granulosus Glutaredoxin 1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610554270.6A CN106093435B (en) 2016-07-14 2016-07-14 The application of Echinococcus granulosus Glutaredoxin 1

Publications (2)

Publication Number Publication Date
CN106093435A CN106093435A (en) 2016-11-09
CN106093435B true CN106093435B (en) 2018-01-23

Family

ID=57221321

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610554270.6A Active CN106093435B (en) 2016-07-14 2016-07-14 The application of Echinococcus granulosus Glutaredoxin 1

Country Status (1)

Country Link
CN (1) CN106093435B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107201348B (en) * 2017-05-27 2021-02-12 兰州大学 Echinococcus granulosus Sigma-glutathione S-transferase recombinant protein and soluble expression method and purification method thereof
CN110261615B (en) * 2019-07-04 2021-10-15 中国动物疫病预防控制中心(农业农村部屠宰技术中心) Cystic echinococcosis diagnostic kit and application thereof
CN110794134B (en) * 2019-11-22 2023-03-10 四川农业大学 Application of Eimeria siei SAG4 protein
CN110988340B (en) * 2019-11-22 2023-03-10 四川农业大学 Application of Eimeria siei SAG8 protein
CN113354722B (en) * 2021-06-09 2022-12-09 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Application of echinococcus granulosus Severin protein in kit for detecting cystic echinococcosis and echinococcus granulosus infection

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101555483A (en) * 2009-05-19 2009-10-14 中山大学 Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof
CN102168100A (en) * 2011-02-14 2011-08-31 中国疾病预防控制中心寄生虫病预防控制所 Echinococcus granulosusglutathione transferase gene and application thereof
CN102731641A (en) * 2012-04-10 2012-10-17 中国农业科学院兰州兽医研究所 Modification of echinococcus granulosus EG95 protein, and expression thereof in yeast
CN102863524A (en) * 2012-08-28 2013-01-09 中国疾病预防控制中心寄生虫病预防控制所 Recombinant antigen protein for diagnosing echinococcosis granulosa as well as preparation method and application thereof
CN104357445A (en) * 2014-10-23 2015-02-18 吕海龙 Interfering RNA for inhibiting and treating echinococcus granulosus disease and application thereof
CN104651328A (en) * 2014-12-31 2015-05-27 中国疾病预防控制中心寄生虫病预防控制所 Novel positive antigen of echinococcus granulosus and application of antigen

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101555483A (en) * 2009-05-19 2009-10-14 中山大学 Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof
CN102168100A (en) * 2011-02-14 2011-08-31 中国疾病预防控制中心寄生虫病预防控制所 Echinococcus granulosusglutathione transferase gene and application thereof
CN102731641A (en) * 2012-04-10 2012-10-17 中国农业科学院兰州兽医研究所 Modification of echinococcus granulosus EG95 protein, and expression thereof in yeast
CN102863524A (en) * 2012-08-28 2013-01-09 中国疾病预防控制中心寄生虫病预防控制所 Recombinant antigen protein for diagnosing echinococcosis granulosa as well as preparation method and application thereof
CN104357445A (en) * 2014-10-23 2015-02-18 吕海龙 Interfering RNA for inhibiting and treating echinococcus granulosus disease and application thereof
CN104651328A (en) * 2014-12-31 2015-05-27 中国疾病预防控制中心寄生虫病预防控制所 Novel positive antigen of echinococcus granulosus and application of antigen

Also Published As

Publication number Publication date
CN106093435A (en) 2016-11-09

Similar Documents

Publication Publication Date Title
CN106093435B (en) The application of Echinococcus granulosus Glutaredoxin 1
CN102731615B (en) Detection reagent and detection method for PRRSV
CN103756973B (en) A kind of indirect ELISA testing kit of GCRV
CN111793591B (en) Salmonella mutant strain capable of efficiently stimulating immune response and construction method and application thereof
CN105695420A (en) Mouse bone marrow hybridoma cell strains, monoclonal antibody generated by same and application
CN106810602A (en) Protein and its application that arch insect infection Mice brain tissues differential expression protein and brain development regulatory protein interact
CN101915835B (en) Lily mottle virus double-antibody sandwich enzyme-linked immunosorbent assay kit and preparation method
CN102690327B (en) Enterovirus 71 neutralized epitope polypeptide and application thereof
CN106596934B (en) A kind of kit for detecting O-shaped foot and mouth disease virus
CN106198979B (en) The application of Echinococcus granulosus dihyrofolate reductase
CN103539839A (en) Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof
CN108752471A (en) The preparation method and applications of anti-PCV2 monoclonal antibodies
CN109239351A (en) A kind of lotus rhizome cryptovirus double antibody sandwich enzyme immunity detection reagent and preparation and detection method
CN107312088A (en) Porcine epidemic diarrhea virus specificity SIgA ELISA detection kits and its application
CN107576791A (en) One boar lawsonia intracellularis ELISA detection kit
CN106198978B (en) The application of Echinococcus granulosus leucine aminopeptidase
CN110257405A (en) Mycoplasma bovis alcohol dehydrogenase gene and its coding albumen and application
CN106990252A (en) Method and kit for diagnostic activities tuberculosis
CN110051832A (en) A kind of heart worm disease vaccine
CN105543177A (en) Hybridoma cell strain secreting citrus yellow vein clearing virus-resistant monoclonal antibodies and monoclonal antibody application thereof
CN108101974A (en) Fasciola hepatica multi-epitope fusion diagnosis antigen and its application and preparation method
DE69734893T2 (en) RECOMBINANT FUSION PROTEINS OF THE REPRODUCTIVE AND RESPIRATORY SYNDROME OF VIRUS FROM THE PIG (PRRSV) AND THEIR USE IN DIAGNOSIS
CN110133290B (en) ELISA kit for diagnosing heartworm disease
CN106397546A (en) O type foot-and-mouth disease virus artificial recombinant antigen and preparation and application thereof
CN108840925A (en) It is a kind of from the anti-WSSV peptide LvHcL48 of hemocyanin in shrimp Litopenaeus vannamei and its application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant